Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ralph D Sanderson

Novel Heparanase Inhibitors for Cancer Therapy

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Robert Hoover

Nordic Countries Linked Medical Birth and Cancer Registries Project

Multiple myeloma and immunoproliferative diseases Breast

Richard J Jones

Bone Marrow Transplantation in Human Disease

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia

Hematology and hematologic malignancies

Irene M. Ghobrial

Stroma-mediated clonal evolution in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases

Wei Gu

HAUSP inhibitors in p53-wild type and p53-mutant tumors

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Colorectum

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jens G Lohr

Determining the mutational landscape of circulating multiple myeloma cells

Multiple myeloma and immunoproliferative diseases

Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma Breast